Idiopathic inflammatory myopathies: current insights and future frontiers

CM Connolly, L Gupta, M Fujimoto… - The Lancet …, 2024 - thelancet.com
Idiopathic inflammatory myopathies are a group of autoimmune diseases with a broad
spectrum of clinical presentations, primarily characterised by immune-mediated muscle …

Inclusion body myositis: Correcting mitochondfrial and lysosomal autophagy impairment as a potential therapeutic strategy

S Brady, J Poulton, S Muller - Autoimmunity Reviews, 2024 - Elsevier
Inclusion body myositis (IBM) is a late onset sporadic myopathy with a characteristic clinical
presentation, but as yet unknown aetiology or effective treatment. Typical clinical features …

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre …

M Benatar, T Hansen, D Rom, MA Geist… - The Lancet …, 2024 - thelancet.com
Background Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder
leading to muscle weakness and respiratory failure. Arimoclomol, a heat-shock protein-70 …

Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis

S Salam, J Allen, MM Dimachkie… - Clinical and …, 2024 - discovery.ucl.ac.uk
Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects
patients aged above 40. IBM does not respond to immunosuppression and no proven …

Inflammatory myopathies in 2024: Better classify them to better treat them

O Benveniste - Revue Neurologique, 2024 - Elsevier
The discovery, over the last forty years or so, of specific myositis auto-antibodies (easily
dosed in routine nowadays) and the fine clinically and pathologically phenotypic …

Biological biomarkers in muscle diseases relevant for follow-up and evaluation of treatment

MG Stemmerik, G Tasca, NE Gilhus, L Servais, A Vicino… - Brain, 2024 - academic.oup.com
Muscle diseases cover a diverse group of disorders that, in most cases, are hereditary. The
rarity of the individual muscle diseases provides a challenge for researchers when wanting …

Inclusion body myositis: an update

NC Anderson, TE Lloyd - Current Opinion in Rheumatology, 2025 - journals.lww.com
Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

272nd ENMC International Workshop: 10 years of Progress-Revision of the ENMC 2013 Diagnostic Criteria for Inclusion Body Myositis and Clinical Trial Readiness …

JB Lilleker, E Naddaf, CGJ Saris, J Schmidt… - Neuromuscular …, 2024 - Elsevier
Since the publication of the 2013 European Neuromuscular Center (ENMC) diagnostic
criteria for Inclusion Body Myositis (IBM), several advances have been made regarding IBM …

Quantitative muscle MRI in sporadic inclusion body myositis (sIBM): A prospective cohort study

L Schlaffke, R Rehmann, M Froeling… - Journal of …, 2024 - journals.sagepub.com
Background: Sporadic inclusion body myositis (sIBM) is the predominant idiopathic
inflammatory myopathy (IIM) in older people. Limitations of classical clinical assessments …

Inclusion body myositis and immunosenescence: current evidence and future perspectives

NA Allameen, S Salam, V Reddy, PM Machado - Rheumatology, 2024 - academic.oup.com
Inclusion body myositis (IBM) remains an enigmatic and complex muscle disorder where a
deeper understanding of disease pathomechanisms and the identification of potential …